The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Search Results for: QLT

Share Price Performance in Q2 2013 for the Canadian Healthcare Sector: Relatively flat for the larger cap public companies (Part 1)

In order to assess share price performance among the Canadian public healthcare companies, I started with a portfolio of 118 companies for the 2013 assessment. The portfolio has been split into three parts according to the closing share price on December 31, 2012: $1.00 or more (38 companies); $0.10 to $0.99 (53 companies); and less […]

Monday Deal Review: September 31, 2012

Welcome to your Monday Biotech Deal Review for September 31, 2012. This week’s big news is yet another acquisition by Valeant, this time for the U.S rights and inventory of an age-related macular degeneration treatment from QLT Inc. Find more details on this story and others by clicking through.

Monday Biotech Deal Review: January 4, 2010

Welcome back, and happy 2010! If you’ve been away for a couple of weeks, check out the winners and losers from our 2009 Trends, and the year’s top posts. If you’re just here for the deals, don’t fret, we have those too: a busy bunch of closings ended 2009, with almost $12 million flowing into […]

Monday Biotech Deal Review: November 2, 2009

In this week’s Deal Review: SemBioSys hops on the SIFT Tax bandwagon; new deals from Microbix, OPMEDIC and GeneNews; and good updates from iCo Therapeutics, QLT, Noveko and Oncolytics.

This Week in the Twitterverse

A lot of my tweeting this week was live reporting/commentary/snark from the first ever Canadian Science Policy Conference. The conference was a great success and will hopefully spur continued reflection and action in the coming months.  The highlight for me was moderating a panel on commercialization comprising Tom Brzustowski, Ronald Dyck, Jorge Niosi and Mark Romoff. […]

Monday Biotech Deal Review: October 25, 2009

A very busy deal week coincided with a very busy work week (for those of us with day jobs), so allow me a particularly grateful thank-you to Jacob Cawker, who’s been an invaluable help with the Deal Review this and the last several weeks.  After the jump, licenses both inbound, outbound and just tied up (optioned); securities extended and […]

Monday Biotech Deal Review: October 4, 2009

Read on for all the details of QLT’s sale of its U.S. subsidiary, as well as more M&A and a series of securities deals from Canadian companies this week

Monday Deal Review: May 25, 2009

This week’s deal review has a couple of new placements, a couple of new plants, a very interesting claim asserted in Boston, and many, many updates on deals we have previously covered.  Check out the full review

Monday Deal Review: February 2, 2009

Canadian deals we found this week:


Get every new post delivered to your Inbox.

Join 128 other followers